ArticleFrontiers in pharmacology2023

Cost-effectiveness of maintenance niraparib with an individualized starting dosage in patients with platinum-sensitive recurrent ovarian cancer in China.

Yin Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.